AstraZeneca will likely retest its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results

AstraZeneca will likely retest its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results

Business Insider

Published

AstraZeneca said Monday that its vaccine was found to be up to 90% effective at preventing COVID-19. But an error in that trial may warrant a new one.

Full Article